drugset / Trial / NCT02165098

Cariprazine: Comparison of Slow- and Immediate-release Forms

NCT02165098

Phase 1 Completed 160 enrolled Gedeon Richter Plc.
RandomizedParallel-groupOpen-labelTreatment

Summary

The investigators are doing this study to compare blood levels and side effects of cariprazine when it's taken as one of two 'slow release' tablets, or as an 'immediate release' capsule. The investigators will also find out if food affects the absorption of cariprazine into the bloodstream after a 'slow release' tablet.

Timeline

Start
2014-06
Primary completion
2016-02
Completion
2016-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Cariprazine Small molecule

Indications

No indication recorded.